NICE will join over 50 organisations across Europe in a five-year project called HARMONY which will help provide better care to patients with blood cancers. The project aims to create a European-wide data platform that will capture the clinical outcomes that matter most to patients, clinicians and organisations such as NICE. The data included will be patient data, results from clinical trials, registries, hospitals and academic or treatment centres and can be shared across relevant private, academic and public sector organisations to increase understanding of blood cancers.
Professor Carole Longson, director of the centre for health technology evaluation at NICE, said: “NICE is delighted to be contributing to HARMONY. This project will help ensure appropriate data is generated to improve understanding of these diseases and help facilitate the development and subsequent assessment of new treatments.”
Eric Low, former chief executive at Myeloma UK, said: “Working at a pan-European level and harnessing the power of big data should provide the evidence and knowledge needed to optimise current treatment approaches by making sure the right patients get the right treatment at the right time.”